Front Row Advisors LLC Thermo Fisher Scientific Inc. Transaction History

Front Row Advisors LLC

  • $271 Million
  • Q3 2024

A detailed history of Front Row Advisors LLC transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Front Row Advisors LLC holds 5,887 shares of TMO stock, worth $3.11 Million. This represents 1.35% of its overall portfolio holdings.

Number of Shares
5,887
Previous 5,833 0.93%
Holding current value
$3.11 Million
Previous $3.23 Million 12.9%
% of portfolio
1.35%
Previous 1.15%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$531.86 - $624.21 $28,720 - $33,707
54 Added 0.93%
5,887 $3.64 Million
Q2 2024

Aug 15, 2024
SELL
$541.52 - $599.02 $355,778 - $393,556
-657 Reduced 10.12%
5,833 $3.23 Million
Q1 2024

May 14, 2024
BUY
$528.82 - $599.43 $35,959 - $40,761
68 Added 1.06%
6,490 $3.77 Million
Q4 2023

Feb 15, 2024
SELL
$431.41 - $532.94 $10,353 - $12,790
-24 Reduced 0.37%
6,422 $3.41 Million
Q3 2023

Nov 15, 2023
BUY
$498.29 - $574.41 $49,330 - $56,866
99 Added 1.56%
6,446 $3.26 Million
Q2 2023

Aug 14, 2023
SELL
$508.46 - $591.13 $71,184 - $82,758
-140 Reduced 2.16%
6,347 $3.31 Million
Q1 2023

May 22, 2023
BUY
$535.0 - $604.82 $1.47 Million - $1.66 Million
2,746 Added 73.4%
6,487 $3.74 Million
Q1 2023

May 15, 2023
SELL
$535.0 - $604.82 $1.5 Million - $1.69 Million
-2,801 Reduced 42.82%
3,741 $649,000
Q4 2022

Feb 15, 2023
SELL
$484.71 - $571.37 $117,784 - $138,842
-243 Reduced 3.58%
6,542 $3.61 Million
Q3 2022

Nov 15, 2022
SELL
$507.19 - $604.49 $26,881 - $32,037
-53 Reduced 0.78%
6,785 $3.44 Million
Q2 2022

Aug 15, 2022
SELL
$500.9 - $612.21 $12,522 - $15,305
-25 Reduced 0.36%
6,838 $3.72 Million
Q1 2022

May 11, 2022
BUY
$524.0 - $644.92 $201,740 - $248,294
385 Added 5.94%
6,863 $4.05 Million
Q4 2021

Mar 09, 2022
BUY
$569.0 - $667.24 $97,868 - $114,765
172 Added 2.73%
6,478 $4.32 Million
Q3 2021

Nov 03, 2021
BUY
$509.53 - $609.78 $22,419 - $26,830
44 Added 0.7%
6,306 $3.61 Million
Q2 2021

Aug 23, 2021
SELL
$441.0 - $508.24 $216,972 - $250,054
-492 Reduced 7.28%
6,262 $3.46 Million
Q1 2021

Apr 28, 2021
BUY
$439.85 - $518.83 $19,793 - $23,347
45 Added 0.67%
6,754 $3.08 Million
Q4 2020

Feb 25, 2021
SELL
$435.06 - $527.66 $19,577 - $23,744
-45 Reduced 0.67%
6,709 $3.13 Million
Q3 2020

Nov 30, 2020
BUY
$359.77 - $441.52 $13,311 - $16,336
37 Added 0.55%
6,754 $3.06 Million
Q2 2020

Aug 17, 2020
SELL
$275.2 - $362.34 $17,062 - $22,465
-62 Reduced 0.91%
6,717 $2.44 Million
Q1 2020

May 08, 2020
SELL
$255.3 - $340.05 $8,935 - $11,901
-35 Reduced 0.51%
6,779 $2.27 Million
Q4 2019

Feb 14, 2020
SELL
$271.93 - $328.04 $44,868 - $54,126
-165 Reduced 2.36%
6,814 $2.22 Million
Q3 2019

Nov 08, 2019
SELL
$268.46 - $305.43 $11,543 - $13,133
-43 Reduced 0.61%
6,979 $2.03 Million
Q2 2019

Aug 27, 2019
BUY
$257.51 - $295.55 $154,248 - $177,034
599 Added 9.33%
7,022 $2.06 Million
Q1 2019

May 17, 2019
BUY
$212.17 - $273.72 $22,065 - $28,466
104 Added 1.65%
6,423 $1.76 Million
Q4 2018

Feb 13, 2019
BUY
$208.47 - $251.98 $2,084 - $2,519
10 Added 0.16%
6,319 $1.42 Million
Q3 2018

Nov 13, 2018
BUY
$205.57 - $244.32 $14,389 - $17,102
70 Added 1.12%
6,309 $1.39 Million
Q2 2018

Jul 31, 2018
BUY
$203.14 - $219.53 $38,596 - $41,710
190 Added 3.14%
6,239 $1.43 Million
Q1 2018

May 21, 2018
BUY
$192.98 - $224.11 $45,157 - $52,441
234 Added 4.02%
6,049 $1.25 Million
Q4 2017

Feb 01, 2018
BUY
$182.03 - $200.37 $1.06 Million - $1.17 Million
5,815
5,815 $1.1 Million

Others Institutions Holding TMO

# of Institutions
2,835
Shares Held
333M
Call Options Held
2.37M
Put Options Held
2.75M
View Full List

About THERMO FISHER SCIENTIFIC INC.

TMO Quotes by TradingView
  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $207B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Front Row Advisors LLC Portfolio

Follow Front Row Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Front Row Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Front Row Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email